Concepts (83)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Computed Tomography Angiography | 2 | 2019 | 236 | 1.140 |
Why?
|
| Free Tissue Flaps | 2 | 2019 | 372 | 0.940 |
Why?
|
| Monoclonal Gammopathy of Undetermined Significance | 1 | 2020 | 32 | 0.740 |
Why?
|
| Dermatofibrosarcoma | 1 | 2020 | 72 | 0.710 |
Why?
|
| Liposarcoma, Myxoid | 1 | 2019 | 39 | 0.700 |
Why?
|
| Musculoskeletal System | 1 | 2019 | 35 | 0.700 |
Why?
|
| Scapula | 1 | 2019 | 37 | 0.680 |
Why?
|
| Ossification, Heterotopic | 1 | 2019 | 70 | 0.670 |
Why?
|
| Chemotherapy-Induced Febrile Neutropenia | 1 | 2018 | 31 | 0.650 |
Why?
|
| Bone Transplantation | 1 | 2019 | 138 | 0.640 |
Why?
|
| Diagnostic Imaging | 3 | 2020 | 1159 | 0.590 |
Why?
|
| Fibula | 1 | 2018 | 148 | 0.580 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2018 | 749 | 0.510 |
Why?
|
| Osteosarcoma | 2 | 2019 | 920 | 0.500 |
Why?
|
| Bone Marrow | 1 | 2018 | 2360 | 0.370 |
Why?
|
| Anuria | 1 | 2009 | 15 | 0.360 |
Why?
|
| Iliac Aneurysm | 1 | 2009 | 12 | 0.360 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2020 | 7717 | 0.360 |
Why?
|
| Multiple Myeloma | 1 | 2020 | 2152 | 0.330 |
Why?
|
| Bone Neoplasms | 1 | 2019 | 2559 | 0.290 |
Why?
|
| Diagnosis, Differential | 6 | 2020 | 4745 | 0.290 |
Why?
|
| Technetium Tc 99m Sestamibi | 1 | 2007 | 121 | 0.290 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2007 | 304 | 0.270 |
Why?
|
| Anaphylaxis | 1 | 2007 | 120 | 0.270 |
Why?
|
| Calcinosis | 2 | 2019 | 426 | 0.260 |
Why?
|
| Skin Neoplasms | 1 | 2020 | 4655 | 0.230 |
Why?
|
| Forearm | 1 | 2023 | 67 | 0.230 |
Why?
|
| Acute Kidney Injury | 1 | 2009 | 744 | 0.200 |
Why?
|
| Fractures, Avulsion | 1 | 2019 | 5 | 0.180 |
Why?
|
| Tendinopathy | 1 | 2019 | 16 | 0.180 |
Why?
|
| Myositis Ossificans | 1 | 2019 | 17 | 0.180 |
Why?
|
| Chondrocalcinosis | 1 | 2019 | 26 | 0.170 |
Why?
|
| Histiocytosis, Sinus | 1 | 2020 | 86 | 0.170 |
Why?
|
| Contrast Media | 3 | 2022 | 1474 | 0.170 |
Why?
|
| Deltoid Muscle | 1 | 2018 | 4 | 0.170 |
Why?
|
| Humans | 18 | 2023 | 262248 | 0.150 |
Why?
|
| Leiomyoma | 1 | 2018 | 147 | 0.150 |
Why?
|
| Gout | 1 | 2019 | 140 | 0.140 |
Why?
|
| Wounds and Injuries | 1 | 2019 | 405 | 0.130 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2020 | 489 | 0.130 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2020 | 600 | 0.130 |
Why?
|
| Radiography | 1 | 2019 | 1900 | 0.130 |
Why?
|
| Ultrasonography | 1 | 2020 | 1869 | 0.110 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2020 | 881 | 0.110 |
Why?
|
| Breast | 1 | 2019 | 1350 | 0.100 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2022 | 7566 | 0.100 |
Why?
|
| Supine Position | 1 | 2009 | 46 | 0.090 |
Why?
|
| Hydronephrosis | 1 | 2009 | 50 | 0.090 |
Why?
|
| Sarcoma | 1 | 2020 | 1725 | 0.090 |
Why?
|
| Iliac Artery | 1 | 2009 | 107 | 0.090 |
Why?
|
| Disease Progression | 1 | 2020 | 6693 | 0.080 |
Why?
|
| Hematologic Neoplasms | 1 | 2020 | 1901 | 0.080 |
Why?
|
| Constriction, Pathologic | 1 | 2009 | 311 | 0.080 |
Why?
|
| Ureter | 1 | 2009 | 210 | 0.080 |
Why?
|
| Embolization, Therapeutic | 1 | 2009 | 552 | 0.060 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2009 | 927 | 0.060 |
Why?
|
| Ovarian Neoplasms | 1 | 2020 | 4660 | 0.060 |
Why?
|
| Hand Strength | 1 | 2023 | 65 | 0.060 |
Why?
|
| Myocardial Ischemia | 1 | 2007 | 433 | 0.060 |
Why?
|
| Stents | 1 | 2009 | 1100 | 0.060 |
Why?
|
| Morbidity | 1 | 2023 | 402 | 0.050 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2022 | 117 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2020 | 10067 | 0.050 |
Why?
|
| Radiopharmaceuticals | 1 | 2007 | 1308 | 0.050 |
Why?
|
| Female | 5 | 2020 | 142293 | 0.040 |
Why?
|
| Gadolinium | 1 | 2020 | 165 | 0.040 |
Why?
|
| Radiation Dosage | 1 | 2022 | 1016 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2022 | 2302 | 0.040 |
Why?
|
| Adult | 2 | 2020 | 78179 | 0.040 |
Why?
|
| Neoplasms | 1 | 2022 | 15180 | 0.030 |
Why?
|
| Middle Aged | 4 | 2020 | 86544 | 0.030 |
Why?
|
| Child | 3 | 2020 | 29067 | 0.030 |
Why?
|
| Retrospective Studies | 3 | 2023 | 38011 | 0.030 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2020 | 845 | 0.030 |
Why?
|
| Aged | 3 | 2020 | 70367 | 0.030 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2020 | 1237 | 0.030 |
Why?
|
| Comorbidity | 1 | 2020 | 2397 | 0.030 |
Why?
|
| Male | 4 | 2020 | 123338 | 0.030 |
Why?
|
| Lymph Nodes | 1 | 2020 | 2969 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2009 | 33028 | 0.020 |
Why?
|
| Young Adult | 1 | 2020 | 21494 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 29996 | 0.010 |
Why?
|
| Adolescent | 1 | 2020 | 31239 | 0.010 |
Why?
|